Clin2
NCT07040280Possibly a fitRecruiting

Sulforaphane supplement to prevent new skin cancers in people with many atypical moles

Clinical Stage 0 Cutaneous Melanoma AJCC v8Clinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage II Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Melanoma AJCC v8Cutaneous Dysplastic Nevus

Part of Cancer, Skin clinical trials.

This study tests a supplement made from broccoli sprouts (sulforaphane) to see if it can reduce the risk of developing new melanomas in people who have had melanoma before and have several unusual moles. Participants will take the supplement daily for a certain period and be monitored for skin changes.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
120 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have had early-stage melanoma in the past, which was removed and has not spread.
  • You have at least 3 unusual (atypical) moles, larger than 5 millimeters, with irregular features.
  • You are not currently taking immunotherapy or targeted therapy for melanoma.
  • You are at least 18 years old.
  • You are willing to use effective birth control if you could become pregnant or father a child.
  • You are not allergic to broccoli or other cruciferous vegetables.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07621614Recruiting· Phase 2
Safe Surgery Guidance for Childhood Melanoma Using Genetics

This study helps doctors decide the safest surgical approach for melanoma and similar skin tumors in children and young adults by using pathology reports and genetic information. The goal is to avoid unnecessary surgery while ensuring the best outcomes.

Oakland, California
NCT06599619Recruiting
Study of PD1 therapy on atypical moles in melanoma patients

This trial tests if an immunotherapy drug (anti-PD1) can change atypical (dysplastic) moles in people who have had melanoma. It may help understand how these drugs affect mole cells.

Pittsburgh, Pennsylvania
NCT07862530Not yet recruiting· Phase 2
Combination drug treatment before surgery for melanoma

This trial tests two drugs given before surgery to shrink melanoma that has spread to lymph nodes. The goal is to see if this combination helps remove the cancer more effectively.

Pittsburgh, Pennsylvania
NCT03934905Recruiting· Phase 1/Phase 2
Sulforaphane supplement to protect the heart during doxorubicin

This trial tests whether a nutritional supplement called sulforaphane (SFN) can help protect heart function in people with breast cancer who are receiving doxorubicin (a chemotherapy that can affect the heart). Participants take caplets and have heart and safety monitoring to see if the supplement reduces heart-related side effects.

Lubbock, Texas
NCT06548789Recruiting· Phase 2
Diet and immunotherapy before surgery for melanoma

This study tests whether adding a special diet (with prebiotic foods) to standard immunotherapy before surgery helps your body fight melanoma better. It may improve how well the treatment works and reduce side effects.

Houston, Texas
NCT06964659Not yet recruiting· Early Phase 1
Broccoli extract supplement for overweight and obese adults

This trial studies a supplement called Sulforaphane-Smart made from broccoli extract. It aims to see if taking it daily for a period helps overweight and obese adults improve their health.

Murcia, Spain

Hear when a new Clinical Stage I Cutaneous Melanoma AJCC v8 trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.